After Surgery High-Risk Prostate Cancer Kept At Bay By Radiation
Main Category: Prostate / Prostate CancerAlso Included In: Radiology / Nuclear Medicine
Article Date: 31 Oct 2007 - 4:00 PDT
| Patient / Public: | ![]() |
4.5 (2 votes) |
| Healthcare Prof: | ![]() |
An analysis of data involving more than 2,000 patients from 17 U.S. institutions demonstrates that men with high-risk prostate cancer who receive radiation therapy after a prostatectomy were less likely to have a recurrence of disease. What's more, men whose cancer persists after surgery were less likely to see the cancer spread if they receive radiation (salvage therapy). These are the conclusions of a study presented at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.
"Our analysis gives us a robust picture of the national experience in treating these high-risk prostate cancers," said Eric M. Horwitz, M.D., clinical director of the radiation oncology department at Fox Chase Cancer Center, Philadelphia, and lead author of the study.
For the study, data from 2,183 men who underwent radiation therapy after radical prostatectomy were available for analysis.
"This is the first time we've applied the new method of defining success to such a large sampling," explained Horwitz. "The results are even more dramatic in favor of post-operative radiation when compared to the old formula. Given our findings, I expect we'll see more men receive and benefit from radiation after prostatectomy for men with high-risk prostate cancer."
###
Fox Chase Cancer Center was founded in 1904 in Philadelphia as the nation's first cancer hospital. In 1974, Fox Chase became one of the first institutions designated as a National Cancer Institute Comprehensive Cancer Center. Fox Chase conducts basic, clinical, population and translational research; programs of prevention, detection and treatment of cancer; and community outreach. For more information about Fox Chase activities, visit the Center's web site at Fox Chase Cancer Center .
Source: Karen Mallet
Fox Chase Cancer Center
Visit our prostate / prostate cancer section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/87258.php>
APA
http://www.medicalnewstoday.com/releases/87258.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




